THE engagement of CD28 with its ligand B7.1/CD80 results in potent cos
timulation of T-cell activation initiated through the CD3/T-cell recep
tor complex(1,2). The biochemical basis of CD28 costimulatory function
is poorly understood. The signalling pathways used by CD28 are unlike
those used by the CD3/T-cell receptor in that they are resistant to c
yclosporin A and independent of changes in cyclic AMP concentrations(3
). These differences suggest that each pathway provides unique biochem
ical information which is required for T-cell activation. We report he
re that CD28 becomes tyrosine-phosphorylated following interaction wit
h B7.1/CD80, which induces formation of a complex with phosphatidylino
sitol-3-OH kinase, mediated by the SH2 domains of the p85 subunit of t
he kinase. Phosphatidylinositol-3-OH kinase is a heterodimer of this 8
5K regulatory subunit and a 110K catalytic subunit, and is a common su
bstrate for most receptor tyrosine kinases and some cytokine receptors
(4,5), binding through its SH2 domain to phosphotyrosine in the motif
Tyr-X-X-Met in the CD28 sequence, which is highly conserved between hu
man, mouse and rat(6-8) and lies in the intracellular domain. We show
that CD28 mutants that have their kinase-binding site deleted or the t
yrosine at position 173 substituted by phenylalanine do not associate
with the kinase after CD28 stimulation and cannot stimulate production
of interleukin-2. Our results suggest that phosphatidylinositol-3-OH
kinase is critical for signalling by CD28.